The COVAX facility, backed by the World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI), has delivered 1.39 billion COVID-19 vaccine doses to 144 countries, GAVI data shows.
By Reuters
Mar 22, 2022
In December COVAX set a target of achieving 70% COVID-19 immunization coverage by mid-2022.
The following tables list countries that have received vaccines under the scheme, sorted alphabetically:
AMERICAS
|
COUNTRY
|
LATEST DELIVERY
|
DELIVERY DATE
|
VACCINE TYPE
|
POPULATION
|
TOTAL DELIVERED
|
|---|---|---|---|---|---|
|
Antigua and Barbuda
|
19,200
|
November 22
|
N/A
|
98,000
|
60,000
|
|
Argentina
|
960,400
|
October 12
|
AstraZeneca/Oxford
|
45 million
|
3.9 million
|
|
Bahamas
|
57,330
|
October 18
|
Pfizer/BioNTech
|
393,000
|
124,530
|
|
Barbados
|
14,040
|
December 16
|
Pfizer/BioNTech
|
287,000
|
114,840
|
|
Belize
|
58,500
|
October 26
|
Pfizer/BioNTech
|
398,000
|
159,300
|
|
Bermuda
|
9,600
|
April 6
|
AstraZeneca/Oxford
|
64,000
|
9,600
|
|
Bolivia
|
1.3 million
|
February 16
|
Pfizer/BioNTech
|
12 million
|
8.0 million
|
|
Brazil
|
2.0 million
|
September 20
|
Sinovac
|
213 million
|
11.9 million
|
|
Chile
|
331,000
|
May 20
|
AstraZeneca/Oxford
|
19 million
|
489,400
|
|
Colombia
|
117,000
|
March 1
|
Pfizer/BioNTech
|
51 million
|
16.6 million
|
|
Costa Rica
|
200,070
|
February 28
|
Pfizer/BioNTech
|
5.1 million
|
1.6 million
|
|
Dominica
|
30,240
|
February 4
|
Moderna
|
72,000
|
133,920
|
|
Dominican Republic
|
184,800
|
August 27
|
AstraZeneca/Oxford
|
11 million
|
463,200
|
|
Ecuador
|
1.5 million
|
February 15
|
Pfizer/BioNTech
|
18 million
|
3.8 million
|
|
El Salvador
|
188,370
|
August 27
|
Pfizer/BioNTech
|
6.5 million
|
3.6 million
|
|
Grenada
|
69,030
|
December 16
|
Pfizer/BioNTech
|
113,000
|
114,630
|
|
Guatemala
|
680,940
|
January 27
|
Pfizer/BioNTech
|
17 million
|
5.0 million
|
|
Guyana
|
28,800
|
January 14
|
J&J
|
787,000
|
291,540
|
|
Haiti
|
151,200
|
February 14
|
Moderna
|
11 million
|
1.1 million
|
|
Honduras
|
349,830
|
March 16
|
Pfizer/BioNTech
|
9.9 million
|
5.1 million
|
|
Jamaica
|
100,000
|
February 21
|
AstraZeneca/Oxford
|
3.0 million
|
1.7 million
|
|
Mexico
|
4.0 million
|
March 4
|
AstraZeneca/Oxford
|
129 million
|
21.3 million
|
|
Nicaragua
|
993,600
|
January 24
|
J&J
|
6.6 million
|
4.7 million
|
|
Panama
|
74,400
|
September 15
|
AstraZeneca/Oxford
|
4.3 million
|
148,800
|
|
Paraguay
|
466,830
|
January 24
|
Pfizer/BioNTech
|
7.1 million
|
1.7 million
|
|
Peru
|
1.2 million
|
November 10
|
Sinopharm
|
33 million
|
3.6 million
|
|
Saint Kitts and Nevis
|
21,600
|
April 7
|
AstraZeneca/Oxford
|
53,000
|
21,600
|
|
Saint Lucia
|
5,040
|
March 16
|
Moderna
|
184,000
|
202,470
|
|
Saint Vincent and the Grenadines
|
70,200
|
December 14
|
Pfizer/BioNTech
|
111,000
|
115,800
|
|
Suriname
|
64,800
|
December 14
|
AstraZeneca/Oxford
|
587,000
|
144,000
|
|
Trinidad and Tobago
|
84,000
|
November 27
|
Sinopharm
|
1.4 million
|
185,200
|
|
Uruguay
|
50,400
|
September 1
|
AstraZeneca/Oxford
|
3.5 million
|
148,800
|
|
Venezuela
|
4.7 million
|
March 14
|
Sinopharm
|
28 million
|
16.8 million
|
Sources: WHO, UNICEF, GAVI, releases from local authorities
…
Read More: Reuters – Factbox: Vaccines delivered under COVAX sharing scheme for poorer countries
…